PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-Feb-2024 VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer Businesswire
07-Feb-2024 Dragos Announces Rick Kramer as Chief Revenue Officer and Angela Crossman as First Chief People Officer Businesswire
07-Feb-2024 Cencora Releases 2023 ESG Report Businesswire
07-Feb-2024 Teva Canada Named by Forbes as No. 1 Canadian Employer in Drugs & Biotechnology Industry Businesswire
07-Feb-2024 Teva Canada classée numéro 1 au tableau des employeurs canadiens de l’industrie pharmaceutique et biotechnologique de Forbes Businesswire
07-Feb-2024 Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program Businesswire
07-Feb-2024 Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research Businesswire
07-Feb-2024 argenx Announces MHRA Licensing of Subcutaneous VYVGART® ▼ (efgartigimod alfa) for generalised Myasthenia Gravis argenx
07-Feb-2024 argenx Announces MHRA Licensing of Subcutaneous VYVGART® ▼ (efgartigimod alfa) for generalised Myasthenia Gravis argenx
07-Feb-2024 Cloud DX Receives $770,000 Order for New Technology Devices and Services AccessWire
07-Feb-2024 Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience Businesswire
07-Feb-2024 TuHURA Biosciences, Inc. Appoints Dennis Yamashita, Ph.D., as Chief Scientific Officer and Head of Discovery Research and Early Development AccessWire
07-Feb-2024 TruLab Integration to Florence Streamlines Biospecimen Data Management for Clinical Sites AccessWire
07-Feb-2024 Get Well Named #1 Market Leader for Patient-Driven Care Management by KLAS AccessWire
07-Feb-2024 Myrobalan Therapeutics Receives a Grant from the ALS Association to Advance its CSF1R Inhibitor Program Businesswire
07-Feb-2024 Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference Businesswire
07-Feb-2024 Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo in Resectable Non-Small Cell Lung Cancer Businesswire
07-Feb-2024 Global Flexible Industrial Packaging Market Outlook 2023-2036: Plastic Material Dominates, Rising Demand for Sustainable Packaging Driving Growth - ResearchAndMarkets.com Businesswire
07-Feb-2024 Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering AccessWire
07-Feb-2024 Delta-Fly Pharma Inc.: Abstracts submission for Phase I Clinical Trial of DFP-14927 to 2024 ASCO annual meeting Businesswire